Literature DB >> 19073433

Dopamine induces supernumerary centrosomes and subsequent cell death through Cdk2 up-regulation in dopaminergic neuronal cells.

Francisco J Diaz-Corrales1, Masato Asanuma, Ikuko Miyazaki, Ko Miyoshi, Nobutaka Hattori, Norio Ogawa.   

Abstract

Aggregation of proteins in the centrosome is implicated in the pathophysiology of Parkinson's disease. However, the relevance of the centrosome in neurodegeneration is still obscure. Centrosome duplication is initiated by the cyclin E/cyclin-dependent kinase 2 (Cdk2) complex. The present study determined changes in cyclin E or Cdk2 expression and in the centrosomal structure in dopaminergic neuronal CATH.a cells exposed to 50, 100 and 150 micromolar dopamine (DA) for 24 h. DA induced significant increase in Cdk2 protein and cyclin E protein, but not cyclin e mRNA. In DA-treated cells, the intense cyclin E- and Cdk2-immunofluorescence signals were co-localized around large and supernumerary centrosomes, and these two parameters of centrosome amplification were significantly increased compared with the control. Simultaneous co-treatment with DA and a Cdk2 inhibitor blocked centrosome amplification and enhanced cell viability. Our results demonstrated that DA could lead to cyclin E accumulation and Cdk2 up-regulation triggering supernumerary centrosomes and apoptotic cell death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19073433     DOI: 10.1007/BF03033854

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  47 in total

Review 1.  Cycling at the interface between neurodevelopment and neurodegeneration.

Authors:  M D Nguyen; W E Mushynski; J-P Julien
Journal:  Cell Death Differ       Date:  2002-12       Impact factor: 15.828

2.  L-dopa and dopamine enhance the formation of aggregates under proteasome inhibition in PC12 cells.

Authors:  Yuko Yoshimoto; Kazuhiro Nakaso; Kenji Nakashima
Journal:  FEBS Lett       Date:  2005-01-21       Impact factor: 4.124

Review 3.  Nigral and extranigral pathology in Parkinson's disease.

Authors:  H Braak; E Braak; D Yilmazer; C Schultz; R A de Vos; E N Jansen
Journal:  J Neural Transm Suppl       Date:  1995

4.  Inhibition of neuronal apoptosis by the cyclin-dependent kinase inhibitor GW8510: identification of 3' substituted indolones as a scaffold for the development of neuroprotective drugs.

Authors:  Kyle Johnson; Li Liu; Nazanin Majdzadeh; Cindy Chavez; Paul C Chin; Brad Morrison; Lulu Wang; Jane Park; Priti Chugh; Hsin-Mei Chen; Santosh R D'Mello
Journal:  J Neurochem       Date:  2005-05       Impact factor: 5.372

5.  Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease.

Authors:  Jin Xu; Shyan-Yuan Kao; Frank J S Lee; Weihong Song; Lee-Way Jin; Bruce A Yankner
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

6.  Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct.

Authors:  K A Conway; J C Rochet; R M Bieganski; P T Lansbury
Journal:  Science       Date:  2001-11-09       Impact factor: 47.728

7.  Cell cycle aberrations by alpha-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies.

Authors:  S S Lee; Y M Kim; E Junn; G Lee; K-H Park; M Tanaka; R D Ronchetti; M M Quezado; M M Mouradian
Journal:  Neurobiol Aging       Date:  2003-09       Impact factor: 4.673

Review 8.  General aspects of neurodegeneration.

Authors:  K A Jellinger
Journal:  J Neural Transm Suppl       Date:  2003

9.  Cytogenetic alterations in lymphocytes of Alzheimer's disease and Parkinson's disease patients.

Authors:  L Petrozzi; C Lucetti; R Scarpato; G Gambaccini; F Trippi; S Bernardini; P Del Dotto; L Migliore; U Bonuccelli
Journal:  Neurol Sci       Date:  2002-09       Impact factor: 3.307

10.  Aggresomes: a cellular response to misfolded proteins.

Authors:  J A Johnston; C L Ward; R R Kopito
Journal:  J Cell Biol       Date:  1998-12-28       Impact factor: 10.539

View more
  3 in total

1.  Aminochrome induces disruption of actin, alpha-, and beta-tubulin cytoskeleton networks in substantia-nigra-derived cell line.

Authors:  Irmgard Paris; Carolina Perez-Pastene; Sergio Cardenas; Patricio Iturriaga-Vasquez; Patricio Iturra; Patricia Muñoz; Eduardo Couve; Pablo Caviedes; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2010-01-20       Impact factor: 3.911

2.  Cell-based assays for Parkinson's disease using differentiated human LUHMES cells.

Authors:  Xiao-Min Zhang; Ming Yin; Min-Hua Zhang
Journal:  Acta Pharmacol Sin       Date:  2014-07       Impact factor: 6.150

3.  Cytoplasmic nucleophosmin has elevated T199 phosphorylation upon which G2/M phase progression is dependent.

Authors:  Narisa Chan; Tit Meng Lim
Journal:  Sci Rep       Date:  2015-06-30       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.